Signal Diagnostics Agrees to Pay over $20M to Settle False Claims Act Allegations for Failing to Refund Overpayments to the HRSA Uninsured Program
Signal Diagnostics LLC (Signal) has agreed to pay the United States $20.5 million to resolve allegations that Signal violated the False Claims Act by knowingly retaining and improperly avoiding its obligations to repay the Health Resources & Services Administration (HRSA) COVID-19 Claims Reimbursement to Health Care Providers and Facilities for Testing, Treatment, and Vaccine Administration for the Uninsured Program (the “Uninsured Program”) for overpayments for claims Signal submitted for patients who had health insurance.
Action Details
- Date:Sept. 30, 2026, 8:39 a.m.
- Agency:U.S. Department of Justice
-
Enforcement Types:
- COVID-19,
- Criminal and Civil Actions